Archive of the journal «Russian otorhinolaryngology» - Medical scientific journal «Russian otorhinolaryngology»

Medical Scientific Journal
Russian
Otorhinolaryngology
9, Bronnitskaya Str., Saint Petersburg, 190013, Russia
Tel./Fax: (921) 922-36-77, e-mail: text@pfco.ru
 ISSN 2413-4309 (online), ISSN 1810-4800 (print)  
Rossiiskaya otorinolaringologiya
Go to content
◄◄   |   
  |    ►►
Section: Section Science articles
The prospects of allergic rhinitis therapy based on high-technology developments
M. V. Filatov (1), A. M. Mel’nik (2), V. V. Dvoryanchikov (2), V. S. Isachenko (2), A. V. Voronov (2)
(1) Federal State Budgetary Institution B. P. Konstantinov Petersburg Nuclear Physics Institute, Gatchina, Saint Petersburg, Russia (2) Federal State Budgetary Military Educational Institution of Higher Vocational Education Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation, Saint Petersburg, Russia
UDK: 616.211-002.193-056.3-08
DOI: https://doi.org/10.18692/1810-4800-2017-4-91-96
ABSTRACT
Allergies are a global medical problem, because about 25% of the population in some industrial regions suffers from any allergic disease, the prevalence of allergies is steadily growing around the world, which is apparently associated with the global changes in human environment. The achievements of the recent years have resulted in new medical technologies based on the ≪exploitation≫ of dendritic cells. Dendritic cells are professional antigen-presenting cells of the immune system that are capable of both stimulating and suppressing the immune response. The use of immunoregulatory potential of dendritic cells is promising for treatment of oncological diseases, autoimmune diseases and prevention of transplant rejection. Clinical trials show that dendritic cells-based vaccines can efficiently induce an immune response against the antigens presented to them. In the course of scientific research, the authors developed a concept of medical technology of using dendritic cells to treat allergies. Dendritic cells, obtained from the patient’s blood cells, were loaded with allergens, producing allergic reactions. The cells of the particular person obtained this way were returned to it by means of intradermal injection. In essence, the suggested procedure is an enhanced version of the widely used hyposensitization method. However, the use of dendritic cells in cocombination with activated lymphocytes resulted in radical increase in the efficiency of the suggested approach.
Publication date:
25.06.2017
Keywords:
allergic rhinitis, dendritic cells.
For citation:
Filatov M. V., Mel’nik A. M., Dvoryanchikov V. V., Isachenko V. S., Voronov A. V. The prospects of allergic rhinitis therapy based on high-technology developments. Rossiiskaya otorinolaringologiya. 2017;4:91–96. https://doi.org/10.18692/1810-4800-2017-4-91-96
All rights to this publication are registered. Link to Russian Otorhinolaryngology Journal is required.
Reprinting of both individual articles and the Journal itself without the publisher`s permission is prohibited.
The Journal editors and publisher are not liable for the content and accuracy of advertising information.
© St. Petersburg Research Institute of Ear, Throat, Nose, and Speech of the Ministry of Health of Russia
© Scientific Clinical Center of Otorhinolaryngology, FMBA of Russia
Логотип журнала "Российская оториноларингология"
© Co. Ltd. Polyforum Group, 2012—
Яндекс.Метрика
Back to content